Aikaterini Lalatsa

ResearcherID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Venues

Pharmaceutics

Molecular pharmaceutics

Journal of immunology research

ACS infectious diseases

School of Pharmacy, University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

School of Pharmacy, University of London Sep 17o 2005 - Oct 31o 2009

United Kingdom

PHD :: Pharmaceutics

Publications

Sarah Kymberly Santos de Lima, Italo Novais Cavallone, Dolores Remedios Serrano, Brayan J Anaya, Aikaterini Lalatsa, Marcia Dalastra Laurenti, João Henrique Ghilardi Lago, Dalete Christine da Silva Souza, Gabriela Pustiglione Marinsek, Beatriz Soares Lopes, Renata de Britto Mari, Luiz Felipe Domingues Passero
Therapeutic Activity of a Topical Formulation Containing 8-Hydroxyquinoline for Cutaneous Leishmaniasis. Pharmaceutics 15 (11) (2023)
Aytug Kara, Dinesh Kumar, Anne Marie Healy, Aikaterini Lalatsa, Dolores Remedios Serrano
Continuous Manufacturing of Cocrystals Using 3D-Printed Microfluidic Chips Coupled with Spray Coating. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Dolores Remedios Serrano, Aytug Kara, Iván Yuste, Francis C Luciano, Baris Ongoren, Brayan J Anaya, Gracia Molina, Laura Diez, Bianca I Ramirez, Irving O Ramirez, Sergio A Sánchez-Guirales, Raquel Fernández-García, Liliana Bautista, Helga K Ruiz, Aikaterini Lalatsa
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals. Pharmaceutics 15 (2) (2023)
Dolores Remedios Serrano, Aytug Kara, Iván Yuste, Francis C Luciano, Baris Ongoren, Brayan J Anaya, Gracia Molina, Laura Diez, Bianca I Ramirez, Irving O Ramirez, Sergio A Sánchez-Guirales, Raquel Fernández-García, Liliana Bautista, Helga K Ruiz, Aikaterini Lalatsa
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals. Pharmaceutics 15 (2) (2023)
Dolores Remedios Serrano, Aytug Kara, Iván Yuste, Francis C Luciano, Baris Ongoren, Brayan J Anaya, Gracia Molina, Laura Diez, Bianca I Ramirez, Irving O Ramirez, Sergio A Sánchez-Guirales, Raquel Fernández-García, Liliana Bautista, Helga K Ruiz, Aikaterini Lalatsa
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals. Pharmaceutics 15 (2) (2023)
Dolores Remedios Serrano, Aytug Kara, Iván Yuste, Francis C Luciano, Baris Ongoren, Brayan J Anaya, Gracia Molina, Laura Diez, Bianca I Ramirez, Irving O Ramirez, Sergio A Sánchez-Guirales, Raquel Fernández-García, Liliana Bautista, Helga K Ruiz, Aikaterini Lalatsa
3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals. Pharmaceutics 15 (2) (2023)
Miriam Rolon, Eustine Hanna, Celeste Vega, Cathia Coronel, Maria Auxiliadora Dea-Ayuela, Dolores Remedios Serrano, Aikaterini Lalatsa
Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease. Pharmaceutics 14 (9) (2022)
Karim Osouli-Bostanabad, Tahereh Masalehdan, Robert M I Kapsa, Anita Quigley, Aikaterini Lalatsa, Kiara F Bruggeman, Stephanie J Franks, Richard J Williams, David R Nisbet
Traction of 3D and 4D Printing in the Healthcare Industry: From Drug Delivery and Analysis to Regenerative Medicine. ACS biomaterials science & engineering 8 (7) (2022)
Dien Puji Rahayu, Roger R Draheim, Aikaterini Lalatsa, Marta Roldo
Harnessing the Antibacterial Properties of Fluoridated Chitosan Polymers against Oral Biofilms. Pharmaceutics 14 (3) (2022)
Karim Osouli-Bostanabad, Sara Puliga, Dolores Remedios Serrano, Andrea Bucchi, Gavin Halbert, Aikaterini Lalatsa
Microfluidic Manufacture of Lipid-Based Nanomedicines. Pharmaceutics 14 (9) (2022)
Adriana Bezerra-Souza, Jéssica Adriana Jesus, Marcia Dalastra Laurenti, Aikaterini Lalatsa, Dolores R Serrano, Luiz Felipe Domingues Passero
Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis. Journal of immunology research 2021 (2021)
Aytug Kara, Athina Vassiliadou, Baris Ongoren, William Keeble, Richard Hing, Aikaterini Lalatsa, Dolores Remedios Serrano
Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines. Pharmaceutics 13 (12) (2021)
Sergio A Sánchez-Guirales, Noelia Jurado, Aytug Kara, Aikaterini Lalatsa, Dolores Remedios Serrano
Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case Study for Nifedipine Minitablets. Pharmaceutics 13 (10) (2021)
Aikaterini Lalatsa, Yujiao Sun, Jose Ignacio Gamboa, Shira Knafo
Preformulation Studies of a Stable PTEN-PDZ Lipopeptide Able to Cross an In Vitro Blood-Brain-Barrier Model as a Potential Therapy for Alzheimer's Disease. Pharmaceutical research 37 (10) (2020)
Jose R Cerda, Talaya Arifi, Sejad Ayyoubi, Peter Knief, Maria Paloma Ballesteros, William Keeble, Eugen Barbu, Anne Marie Healy, Aikaterini Lalatsa, Dolores Remedios Serrano
Personalised 3D Printed Medicines: Optimising Material Properties for Successful Passive Diffusion Loading of Filaments for Fused Deposition Modelling of Solid Dosage Forms. Pharmaceutics 12 (4) (2020)
Raquel Fernández-García, Larry Statts, Jéssica A de Jesus, Maria Auxiliadora Dea-Ayuela, Liliana Bautista, Rúben Simão, Francisco Bolás-Fernández, Maria Paloma Ballesteros, Marcia Dalastra Laurenti, Luiz F D Passero, Aikaterini Lalatsa, Dolores Remedios Serrano
Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases. ACS infectious diseases 6 (10) (2020)
Dolores Remedios Serrano, Raquel Fernandez-Garcia, Marta Mele, Anne Marie Healy, Aikaterini Lalatsa
Designing Fast-Dissolving Orodispersible Films of Amphotericin B for Oropharyngeal Candidiasis. Pharmaceutics 11 (8) (2019)
Adriana Bezerra-Souza, Raquel Fernandez-Garcia, Gabriela F Rodrigues, Francisco Bolas-Fernandez, Marcia Dalastra Laurenti, Luiz Felipe Passero, Aikaterini Lalatsa, Dolores Remedios Serrano
Repurposing Butenafine as An Oral Nanomedicine for Visceral Leishmaniasis. Pharmaceutics 11 (7) (2019)
Lindsay Smith, Dolores R Serrano, Marion Mauger, Francisco Bolás-Fernández, Maria Auxiliadora Dea-Ayuela, Aikaterini Lalatsa
Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis. Molecular pharmaceutics 15 (7) (2018)
Miriam Rolón, Dolores R Serrano, Aikaterini Lalatsa, Esther de Pablo, Juan Jose Torrado, Maria Paloma Ballesteros, Anne Marie Healy, Celeste Vega, Cathia Coronel, Francisco Bolás-Fernández, Maria Auxiliadora Dea-Ayuela
Engineering Oral and Parenteral Amorphous Amphotericin B Formulations against Experimental Trypanosoma cruzi Infections. Molecular pharmaceutics 14 (4) (2017)

Aikaterini Lalatsa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Aikaterini Lalatsa